Modulation of gamma oscillations as a possible therapeutic tool for neuropsychiatric diseases: A review and perspective

Gamma oscillations (30–80 Hz) are well-known for their role in cortical signal transmission and cognitive brain functions. Aberrant gamma activity has been observed in various neuropsychiatric disorders, but the clinical potential of restoring gamma oscillations via noninvasive brain stimulation has...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:International journal of psychophysiology Ročník 152; s. 15 - 25
Hlavní autori: Strüber, Daniel, Herrmann, Christoph S.
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Netherlands Elsevier B.V 01.06.2020
Predmet:
Alzheimer
EEG
Gamma
Neuropsychiatric disorders
Rhythmic stimulation
tACS
tACS
Gamma
Rhythmic stimulation
Neuropsychiatric disorders
Alzheimer
EEG
ISSN:0167-8760, 1872-7697, 1872-7697
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:Gamma oscillations (30–80 Hz) are well-known for their role in cortical signal transmission and cognitive brain functions. Aberrant gamma activity has been observed in various neuropsychiatric disorders, but the clinical potential of restoring gamma oscillations via noninvasive brain stimulation has been widely neglected. Only recently, therapeutic effects of gamma entrainment were documented in mouse models of Alzheimer's dementia (AD) using rhythmic sensory stimulation. In the present review, we first summarize the current status of the research on gamma entrainment in mouse models of AD and human AD patients. Then, we suggest transcranial alternating current stimulation (tACS) as an alternative brain stimulation technique and review the recent literature on the effects of gamma tACS in healthy volunteers and neuropsychiatric diseases to document the efficacy of gamma tACS in improving cognitive functions. We discuss several advantages of tACS compared to rhythmic sensory stimulation for the entrainment of gamma oscillations in the human brain and emphasize the need for more clinical studies applying tACS to drive gamma oscillations and, in turn, to improve cognitive functioning not only in AD but also in patients suffering from other neuropsychiatric disorders. •We review the current status on research about tACS in the gamma frequency band in healthy participants.•We address the importance of gamma-band oscillations in neuropsychiatric diseases.•We propose that using tACS may be used to modulate disturbed gamma-band oscillations in neuropsychiatric diseases.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:0167-8760
1872-7697
1872-7697
DOI:10.1016/j.ijpsycho.2020.03.003